These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 8206610)

  • 41. Exaggerated tubuloglomerular feedback activity in genetic hypertension is mediated by ANG II and AT1 receptors.
    Brännström K; Morsing P; Arendshorst WJ
    Am J Physiol; 1996 May; 270(5 Pt 2):F749-55. PubMed ID: 8928835
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Changes in angiotensin II receptor density and calcium handling during proliferation in SHR aortic myocytes.
    Côrtes SF; Lemos VS; Corriu C; Stoclet JC
    Am J Physiol; 1996 Dec; 271(6 Pt 2):H2330-8. PubMed ID: 8997290
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Temporary losartan or captopril in young SHR induces malignant hypertension despite initial normotension.
    Racasan S; Hahnel B; van der Giezen DM; Blezer EL; Goldschmeding R; Braam B; Kriz W; Koomans HA; Joles JA
    Kidney Int; 2004 Feb; 65(2):575-81. PubMed ID: 14717927
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Plasma and tissue concentrations of proangiotensin-12 in rats treated with inhibitors of the renin-angiotensin system.
    Nagata S; Kato J; Kuwasako K; Asami M; Kitamura K
    Hypertens Res; 2012 Feb; 35(2):234-8. PubMed ID: 21993212
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The effect of angiotensin converting enzyme inhibitors on isolated glomeruli.
    Aber GM; Harding P; Stonier C; Messenger A
    J Hypertens Suppl; 1989 Sep; 7(7):S15-9; discussion S19-20. PubMed ID: 2559169
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Enalapril decreases angiotensin II receptors in subfornical organ of SHR.
    Nazarali AJ; Gutkind JS; Correa FM; Saavedra JM
    Am J Physiol; 1989 Jun; 256(6 Pt 2):H1609-14. PubMed ID: 2544109
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Differential pressor and renal vascular reactivity to angiotensin II in spontaneously hypertensive and Wistar-Kyoto rats.
    Guidi E; Hollenberg NK
    Hypertension; 1987 Jun; 9(6):591-7. PubMed ID: 3294592
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Angiotensin II-induced phosphorylation of the AT1 receptor from rat brain neurons.
    Yang H; Lu D; Raizada MK
    Hypertension; 1997 Sep; 30(3 Pt 1):351-7. PubMed ID: 9314416
    [TBL] [Abstract][Full Text] [Related]  

  • 49. N-Palmitoylethanolamide protects the kidney from hypertensive injury in spontaneously hypertensive rats via inhibition of oxidative stress.
    Mattace Raso G; Simeoli R; Russo R; Santoro A; Pirozzi C; d'Emmanuele di Villa Bianca R; Mitidieri E; Paciello O; Pagano TB; Orefice NS; Meli R; Calignano A
    Pharmacol Res; 2013 Oct; 76():67-76. PubMed ID: 23917217
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Renal expression of angiotensin receptors in long-term diabetes and the effects of angiotensin type 1 receptor blockade.
    Bonnet F; Candido R; Carey RM; Casley D; Russo LM; Osicka TM; Cooper ME; Cao Z
    J Hypertens; 2002 Aug; 20(8):1615-24. PubMed ID: 12172324
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Renin-angiotensin system in neonatal rats: induction of a renal abnormality in response to ACE inhibition or angiotensin II antagonism.
    Friberg P; Sundelin B; Bohman SO; Bobik A; Nilsson H; Wickman A; Gustafsson H; Petersen J; Adams MA
    Kidney Int; 1994 Feb; 45(2):485-92. PubMed ID: 8164437
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Angiotensin converting enzyme inhibitor, captopril, inhibits cardiac hypertrophy without changing collagen types and concentration in spontaneously hypertensive rats.
    Kuzuo H; Honda M; Ishinaga Y; Morioka S; Tanaka K; Kuramochi T; Mansoor AM; Yamori Y; Moriyama K
    Clin Exp Pharmacol Physiol; 1993 Apr; 20(4):253-60. PubMed ID: 8485925
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Enhanced interaction between renovascular alpha(2)-adrenoceptors and angiotensin II receptors in genetic hypertension.
    Jackson EK; Herzer WA; Kost CK; Vyas SJ
    Hypertension; 2001 Sep; 38(3):353-60. PubMed ID: 11566904
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [The effects of endothelin blockade on renal expression of angiotensin II type 1 receptor in diabetic hypertensive rats].
    Gu Y; Chen J; Yang H; Zhu W; Lin F; Zhu C; Lin S
    Zhonghua Yi Xue Za Zhi; 2002 Jan; 82(1):10-3. PubMed ID: 11953118
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The neurogenic origin of hypertension in SHR may be mediated by angiotensin II through a receptor different from AT1 and AT2.
    Paré MC; Maltais S; Escher E
    Regul Pept; 1993 Aug; 47(1):81-6. PubMed ID: 8210522
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Captopril modifies gene expression in hypertrophied and failing hearts of aged spontaneously hypertensive rats.
    Brooks WW; Bing OH; Conrad CH; O'Neill L; Crow MT; Lakatta EG; Dostal DE; Baker KM; Boluyt MO
    Hypertension; 1997 Dec; 30(6):1362-8. PubMed ID: 9403554
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Expression and role of angiotensin II type 2 receptor in the kidney and mesangial cells of spontaneously hypertensive rats.
    Goto M; Mukoyama M; Sugawara A; Suganami T; Kasahara M; Yahata K; Makino H; Suga S; Tanaka I; Nakao K
    Hypertens Res; 2002 Jan; 25(1):125-33. PubMed ID: 11924718
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Angiotensin II type 2 receptors contribute to vascular responses in spontaneously hypertensive rats treated with angiotensin II type 1 receptor antagonists.
    Cosentino F; Savoia C; De Paolis P; Francia P; Russo A; Maffei A; Venturelli V; Schiavoni M; Lembo G; Volpe M
    Am J Hypertens; 2005 Apr; 18(4 Pt 1):493-9. PubMed ID: 15831358
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Combined Antihypertensive Therapies That Increase Expression of Cardioprotective Biomarkers Associated With the Renin-Angiotensin and Kallikrein-Kinin Systems.
    Lezama-Martinez D; Flores-Monroy J; Fonseca-Coronado S; Hernandez-Campos ME; Valencia-Hernandez I; Martinez-Aguilar L
    J Cardiovasc Pharmacol; 2018 Dec; 72(6):291-295. PubMed ID: 30422889
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cross-Talk between CB
    Mińczuk K; Schlicker E; Malinowska B
    Cells; 2022 May; 11(9):. PubMed ID: 35563848
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.